Ç︮ÄÚ¹ÚÅÍ ÆÄÀϷθ® Á¦±Õ Ä¡·á°¡ À§¾Ï °ü·Ã À¯ÀüÀÚÀÇ CpG Island °ú¿°±âÈ­¿¡ ¹ÌÄ¡´Â ¿µÇâ
Helicobacter pylori Eradication Modulates Aberrant CpG Island Hypermethylation in Gastric Carcinogenesis

´ëÇѼÒÈ­±âÇÐȸÁö 2016³â 68±Ç 5È£ p.253 ~ p.259

ÃÖÁ¤¹Î(Choi Jung-Min) - ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ³»°úÇб³½Ç
±è»ó±Õ(Kim Sang-Gyun) - ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èº´°ü(Kim Byeong-Gwan) - ¼­¿ï´ëÇб³º´¿ø¿î¿µ ¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø ³»°ú
°í¼ºÁØ(Koh Seong-Joon) - ¼­¿ï´ëÇб³º´¿ø¿î¿µ ¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø ³»°ú
±èÁö¿ø(Kim Ji-Won) - ¼­¿ï´ëÇб³º´¿ø¿î¿µ ¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø ³»°ú
À̱¹·¡(Lee Kook-Lae) - ¼­¿ï´ëÇб³º´¿ø¿î¿µ ¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø ³»°ú

Abstract

Background/Aims: Helicobacter pylori infection induces aberrant DNA methylation in gastric mucosa. We evaluated the long-term effect of H. pylori eradication on promotor CpG island hypermethylation in gastric carcinogenesis.

Methods: H. pylori-positive patients with gastric adenoma or early gastric cancer who underwent endoscopic resection were enrolled. According to H. pylori eradication after endoscopic resection, the participants were randomly assigned to H. pylori eradication or non-eradication group. H. pylori-negative gastric mucosa from normal participants provided the normal control. CpG island hypermethylation of tumor-related genes (p16, CDH1, and RUNX-3) was evaluated by quantitative MethyLight assay in non-tumorous gastric mucosa. The gene methylation rate and median values of hypermethylation were compared after one year by H. pylori status.

Results: In H. pylori-positive patients, hypermethylation of p16 was found in 80.6%, of CDH1 in 80.6%, and of RUNX-3 in 48.4%. This is significantly higher than normal control (p16, 10%; CDH1, 44%; RUNX-3, 16%) (p<0.05). In the H. pylori eradication group, methylation rates of p16 and CDH1 decreased in 58.1% and 61.3% of the patients, and the median values of hypermethylation were significantly lower at one year compared with the non-eradication group. However, RUNX-3 hypermethylation did not differ significantly at one year after H. pylori eradication. The non-eradication group hypermethylation did not change after one year.

Conclusions: H. pylori infection was associated with promotor hypermethylation of genes in gastric carcinogenesis, and H. pylori eradication might reverse p16 and CDH1 hypermethylation.

Å°¿öµå

Helicobacter pylori, CpG hypermethylation, p16, CDH1, Carcinogenesis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
In H. pylori-positive patients, hypermethylation of p16 was found in 80.6%, of CDH1 in 80.6%, and of RUNX-3 in 48.4%. This is significantly higher than normal control (p16, 10%; CDH1, 44%; RUNX-3, 16%) (p<0.05). In the H. pylori eradication group, methylation rates of p16 and CDH1 decreased in 58.1% and 61.3% of the patients, and the median values of hypermethylation were significantly lower at one year compared with the non-eradication group.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå